Wan W et al. found that SAPCD2 is overexpressed in some glioma tumor tissues, in which it is positively correlated with the degree of glioma malignancy, suggesting that SAPCD2 expression level may be a useful biomarker to grade gliomas tumors 25. This evidence concerns the gene SAPCD2 and central nervous system cancer.